The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications

被引:0
|
作者
Steffen M. Heckl
Viva Wiesener
Hans-Michael Behrens
Dita Ulase
Sandra Krüger
Christoph Röcken
机构
[1] Christian-Albrechts-University,Department of Pathology
[2] University Hospital Schleswig–Holstein,Department of Internal Medicine I
[3] Riga Stradins University,Department of Pathology
来源
Gastric Cancer | 2019年 / 22卷
关键词
Gastric cancer; Insulin receptor; HER-2 Proto-Oncogene Protein; Prognosis; Cancer treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1130 / 1142
页数:12
相关论文
共 50 条
  • [21] Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications
    Ock, Chan-Young
    Kim, Tae-Yong
    Lee, Kyung-Hun
    Han, Sae-Won
    Im, Seock-Ah
    Kim, Tae-You
    Bang, Yung-Jue
    Oh, Do-Youn
    GASTRIC CANCER, 2016, 19 (02) : 421 - 430
  • [22] Are Biopsy Specimens Predictive of HER2 Status in Gastric Cancer Patients?
    M. Pirrelli
    M. L. Caruso
    M. Di Maggio
    R. Armentano
    A. M. Valentini
    Digestive Diseases and Sciences, 2013, 58 : 397 - 404
  • [23] Lin28 promotes Her2 expression and Lin28/Her2 predicts poorer survival in gastric cancer
    Wang, Qinchuan
    Zhou, Jichun
    Guo, Jufeng
    Teng, Rongyue
    Shen, Jianguo
    Huang, Yasheng
    Xie, Shuduo
    Wei, Qun
    Zhao, Wenhe
    Chen, Wenjun
    Yuan, Xiaoming
    Chen, Yongxia
    Wang, Linbo
    TUMOR BIOLOGY, 2014, 35 (11) : 11513 - 11521
  • [24] The Impact of Pembrolizumab as a Salvage Therapy Based on HER2 Expression in Advanced Gastric Cancer
    Lim, Sung Hee
    Kim, Min Jung
    Lee, Jeeyun
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Seung Tae
    CANCERS, 2024, 16 (17)
  • [25] Expression of SATB1 and HER2 in gastric cancer and its clinical significance
    Yuan, C. -L.
    Li, L.
    Zhou, X.
    Li, H.
    Han, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (11) : 2256 - 2264
  • [26] HER2 expression and its clinicopathological features in resectable gastric cancer
    Kataoka, Yoshiki
    Okabe, Hiroshi
    Yoshizawa, Akihiko
    Minamiguchi, Sachiko
    Yoshimura, Kenichi
    Haga, Hironori
    Sakai, Yoshiharu
    GASTRIC CANCER, 2013, 16 (01) : 84 - 93
  • [27] HER2 expression and its clinicopathological features in resectable gastric cancer
    Yoshiki Kataoka
    Hiroshi Okabe
    Akihiko Yoshizawa
    Sachiko Minamiguchi
    Kenichi Yoshimura
    Hironori Haga
    Yoshiharu Sakai
    Gastric Cancer, 2013, 16 : 84 - 93
  • [28] Prediction of HER2 status via random forest in 3257 Chinese patients with gastric cancer
    Tian, Shan
    Yu, Rong
    Zhou, Fangfang
    Zhan, Na
    Li, Jiao
    Wang, Xia
    Peng, Xiulan
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (08) : 5015 - 5024
  • [29] The HER2 Gene and HER2 Protein Status and Chromosome 17 Polysomy in Gastric Cancer Cells in Own Material
    Ciesielski, Maciej
    Kruszewski, Wieslaw Janusz
    Smialek, Urszula
    Walczak, Jakub
    Szajewski, Mariusz
    Szefel, Jaroslaw
    Wydra, Jacek
    Kawecki, Krzysztof
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2015, 23 (02) : 113 - 117
  • [30] Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer
    Tominaga, Naoyuki
    Gotoda, Takuji
    Hara, Megumi
    Hale, Matthew D.
    Tsuchiya, Takayoshi
    Matsubayashi, Jun
    Kono, Shin
    Kusano, Chika
    Itoi, Takao
    Fujimoto, Kazuma
    Moriyasu, Fuminori
    Grabsch, Heike I.
    GASTRIC CANCER, 2016, 19 (02) : 553 - 560